Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tudor domain-containing protein 10 (TDRD10) is a widely expressed protein that contains a Tudor domain, a conserved structural motif implicated in the recognition of methylated protein partners and in RNA metabolic processes[4][5]. TDRD10 is found in both the nucleus and cytoplasm and may play general roles such as regulation of RNA metabolism, reflecting the functions of other members of the Tudor domain family[5]. Current gene ontology annotations associate TDRD10 with nucleic acid binding and nucleotide binding activities[4]. Diseases associated with TDRD10, based on limited evidence, include aortic aneurysm[4]. There is no evidence that TDRD10 is a validated or widely pursued therapeutic target, nor are there known drugs that specifically interact with it. There are no prominently described mechanisms of action, biomarker roles, or safety concerns associated with TDRD10 in the literature[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tudor domain-containing protein 10 (TDRD10).